Clinical Trial Update: A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a booster dose of the Ad5-EBOV Ebola vaccine in healthy adults after primary immunization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad5-EBOV (Ebola adenovirus vector vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Ebola Virus Disease | Phase 1 | Status: COMPLETED